Finch Therapeutics Group, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Finch Therapeutics Group, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
  • Finch Therapeutics Group, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
  • Finch Therapeutics Group, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$3.46M.
Deferred Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$3.46M -$3.46M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-25
2022 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.